Leukemia & Lymphoma, Volume 64, Issue 3 (2023)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 64, Issue 3 (2023)

See all volumes and issues
Vol 65, 2024 Volume 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Reviews

Review
Therapeutic approaches for the management of higher risk myelodysplastic syndromes
Chen Wang & David A. Sallman
Pages: 511-524
Published online: 25 Nov 2022
AbstractforTherapeutic approaches for the management of higher risk myelodysplastic syndromes | Full Text | References | PDF (1.3 MB) | EPUB
  • 229 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Ascertaining QUAZARs: slow-motion and light-speed development of oral azacitidine and decitabine
Jonathan Feld, Douglas Tremblay, Shyamala C. Navada & Lewis R. Silverman
Pages: 525-539
Published online: 12 Nov 2022
AbstractforAscertaining QUAZARs: slow-motion and light-speed development of oral azacitidine and decitabine | Full Text | References | PDF (1.2 MB) | EPUB
  • 224 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
TP53-altered higher-risk myelodysplastic syndromes/neoplasms and acute myeloid leukemia: a distinct genetic entity with unique unmet needs
Somedeb Ball, Sanam Loghavi & Amer M. Zeidan
Pages: 540-550
Published online: 02 Nov 2022
AbstractforTP53-altered higher-risk myelodysplastic syndromes/neoplasms and acute myeloid leukemia: a distinct genetic entity with unique unmet needs | Full Text | References | PDF (837.5 KB) | EPUB
  • 397 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Genetics and epigenetics of CLL
Pamella Paul, Georg Stüssi, Alessio Bruscaggin & Davide Rossi
Pages: 551-563
Published online: 12 Dec 2022
AbstractforGenetics and epigenetics of CLL | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 595 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Leukocytosis and MPNs: Where do we stand?
Alexander Coltoff
Pages: 564-572
Published online: 15 Dec 2022
AbstractforLeukocytosis and MPNs: Where do we stand? | Full Text | References | PDF (706.5 KB) | EPUB
  • 189 Views
  • 1 CrossRef citations
  • 0Altmetric

Original Articles

Article
Use of a real-world synthetic control arm for direct comparison of lisocabtagene maraleucel and conventional therapy in relapsed/refractory large B-cell lymphoma
Hoa Van Le, Kim Van Naarden Braun, Grzegorz S. Nowakowski, David Sermer, John Radford, William Townsend, Herve Ghesquieres, Tobias Menne, Edit Porpaczy, Christopher P. Fox, Claudia Schusterbauer, Fei Fei Liu, Lihua Yue, Marc De Benedetti & Jens Hasskarl
Pages: 573-585
Published online: 08 Feb 2023
AbstractforUse of a real-world synthetic control arm for direct comparison of lisocabtagene maraleucel and conventional therapy in relapsed/refractory large B-cell lymphoma | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 4029 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Burkitt lymphoma – no impact of HIV status on outcomes with rituximab-based chemoimmunotherapy
Jing Yuan Tan, Tian Yu Qiu, Jianbang Chiang, Ya Hwee Tan, Valerie Shiwen Yang, Esther Wei Yin Chang, Eileen Poon, Nagavalli Somasundaram, Mohamad Farid, Miriam Tao, Soon Thye Lim & Jason Yongsheng Chan
Pages: 586-596
Published online: 19 Feb 2022
AbstractforBurkitt lymphoma – no impact of HIV status on outcomes with rituximab-based chemoimmunotherapy | Full Text | References | PDF (1.3 MB) | EPUB
  • 250 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Mitigation strategies among cutaneous T-cell lymphoma patients with positive Staphylococcus aureus skin and soft tissue cultures have unclear impacts on the risk of subsequent bacteremia
Pamela B. Allen, Subir Goyal, Jeffrey Switchenko, Erica Tarabadkar, Stephanie Pouch, Priya Parikh, Alex Palmer, Dylan Martini, Esther Kim & Mary Jo Lechowicz
Pages: 597-604
Published online: 07 Jun 2022
AbstractforMitigation strategies among cutaneous T-cell lymphoma patients with positive Staphylococcus aureus skin and soft tissue cultures have unclear impacts on the risk of subsequent bacteremia | Full Text | References | PDF (843.7 KB) | EPUB
  • 251 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma
Meng Lin, Xiaolong Wu, Lei Zhang, Ling Li, Xinhua Wang, Xiaorui Fu, Zhenchang Sun, Xudong Zhang, Linan Zhu, Hui Yu, Yu Chang, Feifei Nan, Jiaqin Yan, Zhiyuan Zhou, Cunzhen Shi, Mingzhi Zhang & Xin Li
Pages: 605-612
Published online: 19 Jan 2023
AbstractforFotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma | Full Text | References | PDF (752.6 KB) | EPUB
  • 157 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
The International Prognostic Score and HIV status predict red cell concentrate transfusion needs in Hodgkin lymphoma
Kudakwashe Simba, Zainab Mohamed, Jessica J. Opie, Lillian F. Andera, Karryn Brown, Jenna Oosthuizen, Katherine Antel, Tareen Dawood, Lydia Van der Vyfer, Cecile Du Toit, Vernon J. Louw & Estelle Verburgh
Pages: 613-620
Published online: 23 Dec 2022
AbstractforThe International Prognostic Score and HIV status predict red cell concentrate transfusion needs in Hodgkin lymphoma | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 147 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry
Diva Baggio, Cameron Wellard, Eliza Chung, Dipti Talaulikar, Colm Keane, Stephen Opat, Pratyush Giri, Adrian Minson, Chan Yoon Cheah, Tasman Armytage, Denise Lee, Geoffrey Chong, Anna Johnston, Tara Cochrane, Neil Waters, Nada Hamad, Erica M. Wood & Eliza A. Hawkes
Pages: 621-627
Published online: 21 Dec 2022
AbstractforAustralian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 279 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
A phase II study to evaluate the efficacy of low-dose rasburicase (1.5mg) in adolescent and adult acute leukemia and high-grade lymphomas with tumor lysis syndrome
Swaratika Majumdar, Neha Sharma, Manju Sengar, Jayashree Thorat, Lingaraj Nayak, Avinash Bonda, Bhausaheb Bagal, Akhil Rajendra, Amit Sethi & Hasmukh Jain
Pages: 628-638
Published online: 08 Mar 2023
AbstractforA phase II study to evaluate the efficacy of low-dose rasburicase (1.5mg) in adolescent and adult acute leukemia and high-grade lymphomas with tumor lysis syndrome | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 345 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
CDK7 inhibition induces apoptosis in acute myeloid leukemia cells and exerts synergistic antileukemic effects with azacitidine in vitro and in vivo
Shuai Zhang, Ru Feng, Jiefei Bai, Shangyong Ning, Xiaodong Xu, Jie Sun, Meng Wu & Hui Liu
Pages: 639-650
Published online: 19 Jan 2023
AbstractforCDK7 inhibition induces apoptosis in acute myeloid leukemia cells and exerts synergistic antileukemic effects with azacitidine in vitro and in vivo | Full Text | References | PDF (3.7 MB) | EPUB
  • 225 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry
Rena Buckstein, Lisa Chodirker, Karen W.L. Yee, Michelle Geddes, Heather A. Leitch, Grace Christou, Versha Banerji, Brian Leber, Dina Khalaf, Eve St-Hilaire, Nicholas Finn, Thomas Nevill, Mary-Margaret Keating, John Storring, Anne Parmentier, Aksharh Thambipillai, Derek Tang, Christopher Westcott, Chris Cameron & Paul Spin
Pages: 651-661
Published online: 06 Jan 2023
AbstractforThe burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry | Full Text | References | PDF (2.1 MB) | EPUB | Supplemental
  • 2094 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
Immunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndrome
David C. Helfgott, Sabrina Racine-Brzostek, Kelsey J. Short, Zhen Zhao, Paul Christos, Itzel Nino, Tina Niu, Jorge Contreras, Ellen K. Ritchie, Pinkal Desai, Michael Samuel & Gail J. Roboz
Pages: 662-670
Published online: 25 Oct 2022
AbstractforImmunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndrome | Full Text | References | PDF (1 MB) | EPUB
  • 237 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Clinical impact of KIR haplotypes in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic hematopoietic stem cell transplantation
Ann M. Moyer, Shahrukh K. Hashmi, Cynthia M. Kroning, Mrinal Patnaik, Mark Litzow, Dennis A. Gastineau, William J. Hogan, Eapen K. Jacob, Justin D. Kreuter, Laurie L. Wakefield & Manish J. Gandhi
Pages: 671-678
Published online: 30 Nov 2022
AbstractforClinical impact of KIR haplotypes in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic hematopoietic stem cell transplantation | Full Text | References | PDF (1.2 MB) | EPUB
  • 125 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Evaluation of the outcomes of newly diagnosed patients with high-risk myelodysplastic syndrome according to the initial therapeutical strategies chosen in usual clinical practice
Maria Julia Montoro, Helena Pomares, Rosa Coll, Teresa Bernal del Castillo, Mar Tormo, Ana Jiménez, Salut Brunet, Javier Casaño, Itziar Oiartzabal, María Díez-Campelo, Fernando Ramos, Rafael Romero, Eduardo Salido-Fiérrez, Carmen Pedro, Joan Bargay, Carolina Muñoz-Novas, Rocío López, Montserrat Rafel, David Valcárcel & on behalf of ERASME study group
Pages: 679-690
Published online: 28 Dec 2022
AbstractforEvaluation of the outcomes of newly diagnosed patients with high-risk myelodysplastic syndrome according to the initial therapeutical strategies chosen in usual clinical practice | Full Text | References | PDF (2.5 MB) | EPUB
  • 1223 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Comorbidity burden and outcomes of older adults with acute promyelocytic leukemia: a National Cancer Database analysis of 2221 patients
Prajwal Dhakal, Elizabeth Lyden, Utsav Joshi, Avantika Pyakuryal, Kah Poh Loh, Heidi Klepin & Vijaya Raj Bhatt
Pages: 691-697
Published online: 11 Jan 2023
AbstractforComorbidity burden and outcomes of older adults with acute promyelocytic leukemia: a National Cancer Database analysis of 2221 patients | Full Text | References | PDF (970.6 KB) | EPUB
  • 137 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
The prognostic significance of CRLF2 expression at diagnosis in adult Ph-negative B-cell precursor acute lymphoblastic leukemia
Jun Wang, Kai Sun, Wen-Min Chen, Xu Wang, Ling-Di Li, Yue Hao, Nan Xu, Hao Jiang, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Xiao-Jun Huang, Qian Jiang & Ya-Zhen Qin
Pages: 698-706
Published online: 15 Jan 2023
AbstractforThe prognostic significance of CRLF2 expression at diagnosis in adult Ph-negative B-cell precursor acute lymphoblastic leukemia | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 251 Views
  • 0 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter to the Editor
Flare-up phenomenon or pseudoprogression after CAR T-cell infusion in non-Hodgkin aggressive lymphomas
Clara Sortais, Stéphanie Cordeil, Estelle Bourbon, Maryam Idlhaj, Emmanuelle Ferrant, Violaine Safar, Camille Golfier, Anne Lazareth, Fadhela Bouafia-Sauvy, Jérémie Tordo, Hervé Ghesquières, Pierre Sesques & Emmanuel Bachy
Pages: 707-711
Published online: 27 Dec 2022
First Page PreviewforFlare-up phenomenon or pseudoprogression after CAR T-cell infusion in non-Hodgkin aggressive lymphomas | Full Text | References | PDF (1 MB) | EPUB
  • 336 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter to the Editor
Zanubrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final results and correlative analysis of lymphocytosis
Wei Xu, Shenmiao Yang, Keshu Zhou, Ling Pan, Zengjun Li, Sujun Gao, Daobin Zhou, Jianda Hu, Ru Feng, Haiwen Huang, Tingyu Wang, Dengju Li, Meng Ji, Haiyi Guo, Xia Zhao, Binghao Wu, Yiling Yu, Yu Wang, Jane Huang, William Novotny & Jianyong Li
Pages: 712-716
Published online: 17 Feb 2023
First Page PreviewforZanubrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final results and correlative analysis of lymphocytosis | Full Text | References | PDF (994.4 KB) | EPUB | Supplemental
  • 1874 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Letter
RUNX1 gene alterations characterized by allelic preference in adult acute myeloid leukemia
Cosimo Cumbo, Giuseppina Tota, Anna De Grassi, Luisa Anelli, Antonella Zagaria, Nicoletta Coccaro, Francesco Tarantini, Crescenzio Francesco Minervini, Elisa Parciante, Luciana Impera, Maria Rosa Conserva, Immacolata Redavid, Anna Mestice, Immacolata Attolico, Ciro Leonardo Pierri, Pellegrino Musto & Francesco Albano
Pages: 717-721
Published online: 24 May 2021
First Page PreviewforRUNX1 gene alterations characterized by allelic preference in adult acute myeloid leukemia | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 150 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
A phase II study of obinutuzumab in combination with ibrutinib for treatment of relapsed mantle cell lymphoma
Myung Sun Kim, Titas Banerjee, Andy Chen, Alexey Danilov, Renee MacKinnon, Bria Thurlow, Sujata Thakurta, Kirsten Orand, Catherine Degnin, Byung Park & Stephen E. Spurgeon
Pages: 722-724
Published online: 09 Mar 2022
First Page PreviewforA phase II study of obinutuzumab in combination with ibrutinib for treatment of relapsed mantle cell lymphoma | Full Text | References | PDF (506.4 KB) | EPUB
  • 2115 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Letter
Excess mortality in younger patients with myeloproliferative neoplasms
Khalid Abu-Zeinah, Khalil Saadeh, Richard T. Silver, Joseph M. Scandura & Ghaith Abu-Zeinah
Pages: 725-729
Published online: 09 May 2022
First Page PreviewforExcess mortality in younger patients with myeloproliferative neoplasms | Full Text | References | PDF (981.4 KB) | EPUB | Supplemental
  • 283 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter to the Editor
Oral azole antifungal prophylaxis in Japanese patients with chronic lymphocytic leukemia receiving ibrutinib: a nationwide cohort study
Takeo Yasu, Kotono Sakurai, Makoto Hoshino & Manabu Akazawa
Pages: 730-733
Published online: 28 Dec 2022
First Page PreviewforOral azole antifungal prophylaxis in Japanese patients with chronic lymphocytic leukemia receiving ibrutinib: a nationwide cohort study | Full Text | References | PDF (500.7 KB) | EPUB
  • 171 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter to the Editor
Chronic lymphocytic leukemia transdifferentiated to blastic neoplasm with T/plasmacytoid dendritic cell immunophenotype
Kimon V. Argyropoulos, Umut Aypar, Mark D. Ewalt, Mikhail Roshal, Ahmet Dogan & Filiz Sen
Pages: 734-737
Published online: 07 Feb 2023
First Page PreviewforChronic lymphocytic leukemia transdifferentiated to blastic neoplasm with T/plasmacytoid dendritic cell immunophenotype | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 171 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter to the Editor
Molecularly targeted epigenetic therapy with mocetinostat in relapsed and refractory non-Hodgkin lymphoma with CREBBP or EP300 mutations: an open label phase II study
David Qualls, Ariela Noy, David Straus, Matthew Matasar, Craig Moskowitz, Venkatraman Seshan, Ahmet Dogan, Gilles Salles, Anas Younes, Andrew D. Zelenetz & Connie Lee Batlevi
Pages: 738-741
Published online: 15 Jan 2023
First Page PreviewforMolecularly targeted epigenetic therapy with mocetinostat in relapsed and refractory non-Hodgkin lymphoma with CREBBP or EP300 mutations: an open label phase II study | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 1296 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Letter to the Editor
Brentuximab vedotin plus bendamustine versus platinum-based regimens as 1st salvage therapy and ‘bridge’ to autologous hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma
Panayotis Kaloyannidis, Mohammed Al Zayer, Mohammed Al Darweesh, Majed Al Batran, Ayed Al Garni, Abdulrahman Al Naim, Hani Al Hashmi & Solaf Kanfar
Pages: 742-745
Published online: 11 Jan 2023
First Page PreviewforBrentuximab vedotin plus bendamustine versus platinum-based regimens as 1st salvage therapy and ‘bridge’ to autologous hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma | Full Text | References | PDF (513.7 KB) | EPUB
  • 185 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter to the Editor
Sudden lymphoid blast crisis after tyrosine kinase inhibitor discontinuation in chronic phase chronic myeloid leukemia: cautionary tales for appropriate molecular monitoring
Alex Bataller, Fadi G. Haddad, Ghayas C. Issa, Koji Sasaki, Elias Jabbour, Gautam Borthakur, Alessandra Ferrajoli & Nicholas J. Short
Pages: 746-749
Published online: 19 Jan 2023
First Page PreviewforSudden lymphoid blast crisis after tyrosine kinase inhibitor discontinuation in chronic phase chronic myeloid leukemia: cautionary tales for appropriate molecular monitoring | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 222 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter to the Editor
Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy
Konstantinos Lontos, Anastasia Tsagianni, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Robert L. Redner, Annie Im, Kathleen A. Dorritie, Alison Sehgal, James Rossetti, Nidhi Aggarwal, Melissa Saul, Michael Boyiadzis & Nathanael G. Bailey
Pages: 750-752
Published online: 01 Feb 2023
First Page PreviewforPrognostic significance of blast immunophenotype on first post-induction bone marrow biopsy | Full Text | References | PDF (626.9 KB) | EPUB
  • 222 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter to the Editor
Should WE use flow cytometry to assess bone marrow involvement by lymphoma?
Rebeca Jurado, Mercè Aren & Marc Sorigue
Pages: 753-755
Published online: 08 Mar 2023
First Page PreviewforShould WE use flow cytometry to assess bone marrow involvement by lymphoma? | Full Text | References | PDF (814 KB) | EPUB
  • 73 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles